New Issue: Citigroup sells $475,000 upturn securities on biotech ETF

Chicago, May 18 – Citigroup Global Markets Holdings Inc. priced $475,000 of 0% upturn securities due July 27, 2023 linked to the SPDR S&P Biotech ETF, according to a 424B2 filing with the Securities and Exchange Commission.

The notes are guaranteed by Citigroup Inc.

If the ETF finishes above its initial share price, the payout at maturity will be par plus 150% of the gain, up to a maximum payout of par plus 47.5%.

If the ETF finishes at or below its initial share price, investors will be exposed to any decline.

Citigroup Global Markets Inc. is the underwriter.

Issuer:	Citigroup Global Markets Holdings Inc.
Guarantor:	Citigroup Inc.
Issue:	Upturn securities
Underlying ETF:	SPDR S&P Biotech ETF
Amount:	$475,000
Maturity:	July 27, 2023
Coupon:	0%
Price:	Par
Payout at maturity:	Par plus 150% of any ETF gain, capped at par plus 47.5%; otherwise, exposure to any decline
Initial share price:	$77.06
Pricing date:	June 24, 2022
Settlement date:	June 29, 2022
Underwriter:	Citigroup Global Markets Inc.
Fees:	1.93%
Cusip:	17330PDD8

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.